ColoVantage® (Methylated Septin 9)
Fasting Required: No

Specimen: Blood

Results: 5-7 Business Days

Description: Methylated Septin9 DNA has been associated with the occurrence of CRC, in plasma obtained from whole-blood specimens. It is indicated for use in average-risk patients who have chosen not to undergo other screening methods, such as colonoscopy or stool-based tests. Methylated Septin 9 is a DNA marker associated with colorectal cancer.

Note: Result turnaround times are an estimate and are not guaranteed. Our reference lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.